WELLS FARGO & COMPANY/MN
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 72971
SAN FRANCISCO, CA
Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,988,669
+$2,910,888 QoQ
Shares Held
411,825
+49.7% QoQ
Ownership
0.310%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. AUPH ranks #40 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in AUPH
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,988,669 | 411,825 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,077,781 | 275,154 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,214,531 | 264,234 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $817,621 | 73,993 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $524,741 | 61,953 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $565,589 | 70,347 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $647,313 | 72,084 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $462,433 | 63,088 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $381,456 | 66,805 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $311,599 | 62,196 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,453,915 | 161,726 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,487,565 | 191,450 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,063,929 | 213,216 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,978,257 | 180,498 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $659,417 | 152,643 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,627,697 | 349,428 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,807,823 | 378,888 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,953,553 | 480,901 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,366,228 | 496,993 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,810,481 | 578,874 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,216,147 | 788,283 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,918,214 | 763,821 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $9,219,035 | 666,597 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $5,573,050 | 378,347 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $2,867,588 | 176,467 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $6,034,026 | 415,853 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||